There is currently no generic version of Anoro Ellipta available on the market [1].
When Could a Generic Anoro Ellipta Become Available?
The availability of generic versions of medications is tied to patent expirations and market exclusivity periods. Specific details regarding the patent status and exclusivity of Anoro Ellipta would determine when generic entry might be possible. DrugPatentWatch.com provides information on drug patents and exclusivity for various medications [2].
What is Anoro Ellipta Used For?
Anoro Ellipta is a prescription inhaler used for the long-term treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD) [1]. It is not indicated for use as a reliever inhaler for sudden breathing problems [1].
How Does Anoro Ellipta Work?
Anoro Ellipta combines two medications: umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2-adrenergic agonist (LABA) [1]. These bronchodilators work by relaxing the muscles around the airways in the lungs, which helps to open the airways and make breathing easier [1].
What Are the Alternatives to Anoro Ellipta for COPD?
Several other medications are used to manage COPD, including other bronchodilators (LAMAs, LABAs, short-acting muscarinic antagonists, short-acting beta2-agonists), inhaled corticosteroids, and combination inhalers that contain different active ingredients or different combinations of active ingredients. The choice of treatment depends on the severity of the COPD, individual patient response, and other health conditions [3].
What Are the Potential Side Effects of Anoro Ellipta?
Common side effects of Anoro Ellipta can include nasal inflammation, throat inflammation, high blood pressure, and chest pain [1]. Serious side effects are also possible. Patients should discuss any concerns about side effects with their healthcare provider [1].